{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:08:26Z","timestamp":1790075306682,"version":"4.0.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNR"],"published-print":{"date-parts":[[2026,9,18]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Neurodegenerative diseases (NDs), including Alzheimer\u2019s disease, Parkinson\u2019s disease,\namyotrophic lateral sclerosis, and Huntington\u2019s disease, are characterized by interacting\npathological processes such as protein aggregation, mitochondrial dysfunction, oxidative stress,\nneuroinflammation, and impaired proteostasis. This narrative review examines how embryonic\/\ninduced pluripotent stem cells, neural stem cells, mesenchymal stem\/stromal cells, immune\ncells, and extracellular vesicles may intervene across these pathological networks. A targeted\nPubMed search and reference-list screening through 5 July 2026 identified relevant mechanistic,\npreclinical, clinical, manufacturing, and regulatory evidence. The reviewed strategies act through\ncell replacement, paracrine support, immunomodulation, metabolic stabilization, and pathological-\nprotein clearance. Evidence maturity differs substantially by disease and product: pluripotent\nstem cell-derived dopaminergic progenitors have entered early clinical evaluation in Parkinson\u2019s\ndisease, whereas most mesenchymal stem\/stromal cell studies remain small and exploratory, and\nimmune-cell and extracellular-vesicle approaches are predominantly preclinical or early translational.\nMajor barriers include product heterogeneity, mechanism-linked potency testing, longterm\nsafety, delivery and dose optimization, disease-stage selection, clinically meaningful endpoints,\nand regulatory comparability. Future development should emphasize standardized manufacturing,\nbiomarker-guided trial design, transparent reporting of negative findings, and rational\ncombinations with pharmacological or gene-based therapies. Cell-based interventions remain\npromising, but durable clinical benefit has not yet been established.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115672026476083260903180127","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:57:57Z","timestamp":1790074677000},"source":"Crossref","is-referenced-by-count":0,"title":["Cell Therapy Targeting Pathological Networks in Neurodegenerative Diseases: Mechanisms and Translation from Stem Cells to Extracellular Vesicles"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4777-3838","authenticated-orcid":true,"given":"Xinyuan","family":"Duan","sequence":"first","affiliation":[{"name":"College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8336-3576","authenticated-orcid":true,"given":"Yanqi","family":"Li","sequence":"additional","affiliation":[{"name":"College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7940-4685","authenticated-orcid":true,"given":"Ruping","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0217-3021","authenticated-orcid":true,"given":"Xue","family":"Jiang","sequence":"additional","affiliation":[{"name":"College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3658-7374","authenticated-orcid":true,"given":"Chao","family":"Xia","sequence":"additional","affiliation":[{"name":"College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6581-3964","authenticated-orcid":true,"given":"Fei","family":"Xie","sequence":"additional","affiliation":[{"name":"College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Neurovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672026476083260903180127","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/258518\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115672026476083260903180127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:58:03Z","timestamp":1790074683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/258518\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115672026476083260903180127","relation":{},"ISSN":["1567-2026"],"issn-type":[{"value":"1567-2026","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}